New diabetes clinical trial: Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes
Published on: 2026-07-22T04:00:00Z Conditions : Type 2 Diabetes Mellitus (T2DM); Atherosclerosis Interventions : Drug: Cilostazol; Drug: Aspirin Sponsors : Seoul National University Bundang Hospital Recruiting https://ift.tt/J0DF9UL